We observed a consistent association between anti-PD-L1 and anti-PD-1 treatment response and m6AScore with that between m6AScore and GBM, which we suggested may be due to the relatively high component of ICs infiltration in the m6AScore high group (Karachi et al., 2018). The gene discussed is CD274; the disease is glioblastoma.